LncRNA-MIAT Increased in Patients with Coronary Atherosclerotic Heart Disease
Background. To study the expression and clinical significance of long noncoding RNA- (lncRNA-) MIAT in patients with coronary atherosclerotic heart disease (CAD). Methods. Serum MIAT, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in 106 CAD patients and 89 healthy donors were detected. C...
Main Authors: | Jin Tan, Shengzhong Liu, Qin Jiang, Tao Yu, Keli Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2019/6280194 |
Similar Items
-
ADSC Exosomes Mediate lncRNA-MIAT Alleviation of Endometrial Fibrosis by Regulating miR-150-5p
by: Xiaowen Shao, et al.
Published: (2021-06-01) -
LncRNA MIAT impairs cardiac contractile function by acting on mitochondrial translocator protein TSPO in a mouse model of myocardial infarction
by: Xue Bai, et al.
Published: (2021-05-01) -
LncRNA-MIAT-Mediated miR-214-3p Silencing Is Responsible for IL-17 Production and Cardiac Fibrosis in Diabetic Cardiomyopathy
by: Yanqing Qi, et al.
Published: (2020-04-01) -
Analysis on the Expression and Prognostic Value of LncRNA FAF in Patients with Coronary Heart Disease
by: Hai Xu, et al.
Published: (2020-01-01) -
Deregulation of miR-520d-3p promotes hepatocellular carcinoma development via lncRNA MIAT regulation and EPHA2 signaling activation
by: Yun Xiang, et al.
Published: (2019-01-01)